A Study of Calcitriol BID Topical Treatment in Adolescents With Plaque Psoriasis
Status:
Completed
Trial end date:
2009-09-24
Target enrollment:
Participant gender:
Summary
This is an open-label, multicenter study to assess the systemic exposure to calcitriol in the
adolescent population. Calcitriol 3µg/g ointment (2 mg/cm² per application) is to be applied
twice daily to involved skin (10 - 35% BSA involved, excluding face, scalp and intertriginous
areas) for 56 days (8 weeks). Full Pharmacokinetic (PK) and Pharmacodynamic (PD) profile will
be collected during the first 3 weeks of the study; safety and efficacy data will be
collected for the 8 weeks of the treatment.